tiprankstipranks
Consun Pharmaceutical Group Ltd. (DE:C1P)
FRANKFURT:C1P
Holding DE:C1P?
Track your performance easily

Consun Pharmaceutical Group Ltd. (C1P) Financial Statements

2 Followers

Consun Pharmaceutical Group Ltd. Financial Overview

Consun Pharmaceutical Group Ltd.'s market cap is currently ―. The company's EPS TTM is €0.134; its P/E ratio is 6.55; and it has a dividend yield of 8.06%. Consun Pharmaceutical Group Ltd. is scheduled to report earnings on March 19, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Jun 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 2.45B¥ 2.43B¥ 2.02B¥ 1.94B¥ 1.52B
Total Assets¥ 4.35B¥ 4.36B¥ 4.01B¥ 3.95B¥ 3.64B
Total Debt¥ 478.37M¥ 610.97M¥ 592.15M¥ 549.41M¥ 585.16M
Net Debt¥ -1.97B¥ -1.82B¥ -1.42B¥ -1.39B¥ -936.00M
Total Liabilities¥ 1.30B¥ 1.45B¥ 1.36B¥ 1.43B¥ 1.32B
Stockholders Equity¥ 2.76B¥ 2.62B¥ 2.36B¥ 2.22B¥ 2.03B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Consun Pharmaceutical Group Ltd. Earnings and Revenue History

Consun Pharmaceutical Group Ltd. Debt to Assets

Consun Pharmaceutical Group Ltd. Cash Flow

Consun Pharmaceutical Group Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis